Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Recordati Rare Diseases, Immeuble Le Wilson, 70, avenue du Général de Gaulle, F-92800 Puteaux, France
Wilzin 50 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. Capsule with orange opaque cap and body, imprinted “93-377”. |
Each hard capsule contains 50 mg of zinc (corresponding to 167.84 mg of zinc acetate dihydrate).
Excipients: Each capsule contains 1.75 mg of sunset yellow FCF (E110)
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zinc |
Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells. |
| List of Excipients |
|---|
|
Capsule content: Maize starch Capsule shell: Gelatin Printing ink: Black iron oxide (E172) |
White HDPE bottle with a polypropylene and HDPE closure and contains a filler (cotton coil). Each bottle contains 250 capsules.
Recordati Rare Diseases, Immeuble “Le Wilson”, 70, avenue du Général de Gaulle, F-92800 Puteaux, France
EU/1/04/286/002
Date of first authorisation: 13 October 2004
Date of latest renewal: 13 October 2009
| Drug | Countries | |
|---|---|---|
| WILZIN | Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
